Wednesday, August 13, 2025
NIH-supported trial finds dalbavancin safe, effective for treating bacteremia
Colorized scanning electron micrograph of methicillin-resistant Staphylococcus aureus (MRSA… [+7699 chars]
Two-dose therapy for S. aureus bloodstream infections on par with standard treatment - National Institutes of Health (NIH) | (.gov)
NIH-supported trial finds dalbavancin safe, effective for treating bacteremia
Source:National Institutes of Health
Published:
Related News
My Parents Kicked Me Out of the House When I Was 14. I Always Dreamed of Having Them Back—But Not Like This. - Slate
It's been nearly two decades.
Slate Magazine•Arionne Nettles
'Aging muscles respond very well to progressive strength training' — a personal trainer shares a 5-move workout to build muscle after 65 - Tom's Guide
Let's build.
Tom's Guide•Jessica Downey
Doctors ignore new federal vaccine recommendations to stick with science - CNN
The American Academy of Pediatrics on Monday released its updated recommendations for what vaccines children should get. It’s a routine revision, hardly different from last year’s recommendations, but it carries more significance this year: More states and do…
CNN•Jen Christensen